Modulation of innate immunological factors by STEALTH® liposome-encapsulated tumor necrosis factor-α in a colon tumor xenograft model

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 777-788

  Kim, Dong W ^a   Andres, Melba L ^a   Kajioka, Eric H ^a   Dutta Roy, Radha ^a   Miller, Glen M ^a   Seynhaeve, Ann L B ^a   Ten Hagen, Timo L M ^a   Gridley, Daila S ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunotherapy; LS174T adenocarcinoma; PEGylated liposome; TNF

Indexed keywords

LIPOSOME; MACROGOL; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOLOGY; CELL ACTIVATION; CELL PROLIFERATION; COLON TUMOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR XENOGRAFT;

ANIMALS; COLONIC NEOPLASMS; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; LIPOSOMES; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, NUDE; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036254119     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts
2. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
3. Encapsulation of the topoisomerase I inhibitor GL14721 IC in pegylated (STEALTH) liposomes- pharmacokinetics and antitumor activity in HT29 colon tumor xenografts
4. Enhanced effects of monoclonal antibody carboplatin immunoconjugates uptake and anti-tumor effects with angiotensin 11 and tumor necrosis factor
5. Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats
6. An endotoxin-induced serum factor that causes necrosis of tumors
7. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro
8. Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: A summary of the Southwest Oncology Group experience
9. High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan
10. Shock and tissue injury induced by recombinant human cachectin
11. A rat extremity soft tissue sarcoma model for the study of systemic treatment with Stealth liposome-encapsulated tumor necrosis factor alpha and cytotoxic agents
12. Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats
13. Stealth liposome technology: An overview
14. Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts
15. Human colonic adenocarcinoma cells. 1. Establishment and description of a new line
16. Acute effects of whole-body proton irradiation on the immune system of the mouse
17. Antigenic structure of human tumour necrosis factor: Recognition of distinct regions of TNF alpha by different tumour cell receptors
18. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: Induction of tumor-specific immunity
19. Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo
20. Role of mast cells and monoamines in the thrombocytopaenia and mortality elicited by tumour necrosis factor in mice
21. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice
22. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft
23. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
24. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
25. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: In vitro and in vivo studies
26. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
27. Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes
28. Effects of proton and gamma radiation on lymphocyte populations and acute response to antigen